Is your child or loved one living with osteogenesis imperfecta (OI)?
If your child or teen is between 5 to 17 years old, they may be eligible to participate in a clinical study evaluating an investigational medication for osteogenesis imperfecta.
The purpose of this phase III study is to determine whether the investigational medication, romosozumab, may help prevent bone fractures and impact bone density in children and teens with osteogenesis imperfecta (OI).
Children and teens may be eligible to participate in this study if they:
Other eligibility criteria apply and will be evaluated by a study doctor if you and your loved one choose to continue with screening for the study.
Participation in this study may provide useful information on osteogenesis imperfecta by helping researchers understand whether romosozumab may help build stronger bones and reduce fractures in children and teens.
By enrolling in this Phase III study, participants may receive:
Access to expert physicians with experience managing osteogenesis imperfecta (OI).
Reasonable reimbursement for parking and travel if qualified for the study.
The study required procedures and investigational medication provided at no cost.
The family of those with osteogenesis imperfecta play an important role in supporting their loved one's health and wellbeing.
If you are a loved one of someone with osteogenesis imperfecta, you can complete the questionnaire for the study on their behalf by clicking the button below. Please enter your contact information so we can follow up with you about the study.
It’s normal to have questions about clinical research and how it might impact your child or loved one. The physicians involved in this study will closely monitor participants. The standard medical care your child (and you) already receive is shaped by previous successful clinical research.
When preparing your child for a clinical research study, it’s helpful to approach the conversation much like you would when explaining a medical treatment. Use simple, age-appropriate language so your child can understand what to expect. For younger children, visuals can be especially helpful—consider drawing or showing pictures that walk through a procedure to make the process feel more familiar and less intimidating.
If your child hasn’t had much experience with medical visits, introducing them to images of doctors, nurses, or a hospital setting can also ease anxiety and help them see that medical professionals are there to help and care for them.
It’s also a good idea to explain why the research matters. You might say something like, “This medicine could help make your bones stronger,” or, “By being part of this study, you’re helping doctors learn more about OI for the future.” Keep the conversation open; encourage your child to ask questions, express their feelings, and share any concerns.
And remember, the study team is there to support you, too. They may have helpful resources designed for children and families like you.
Here are some terms that may be helpful to discuss with your child.
At PatientWing, we’re here to support you at every step of the study. You can email or fill out the form with any questions. We’re here to help.
